Showing results (31-40 of 65) with videos related to
Sort By:
Pageof 7
Biomaterials|August 25, 2011
Liposomes for HIV prophylaxisNikita K Malavia, David Zurakowski, Avi Schroeder, et al.Journal of Virology|May 12, 2017
Induction of a Tier-1-Like Phenotype in Diverse Tier-2 Isolates by Agents That Guide HIV-1 Env to Perturbation-Sensitive, Nonnative StatesJacklyn Johnson, Yinjie Zhai, Hamid Salimi, et al.Accounts of Chemical Research|February 8, 2014
Structure-based design, synthesis and validation of CD4-mimetic small molecule inhibitors of HIV-1 entry: conversion of a viral entry agonist to an antagonistJoel R Courter, Navid Madani, Joseph Sodroski, et al.ACS Medicinal Chemistry Letters|November 19, 2021
Identification of gp120 Residue His105 as a Novel Target for HIV-1 Neutralization by Small-Molecule CD4-MimicsChristopher J Fritschi, Shuaiyi Liang, Mohammadjavad Mohammadi, et al.Plos Pathogens|July 7, 2011
Contribution of intrinsic reactivity of the HIV-1 envelope glycoproteins to CD4-independent infection and global inhibitor sensitivityHillel Haim, Bettina Strack, Aemro Kassa, et al.Biochemistry|August 18, 2012
A novel synthetic bivalent ligand to probe chemokine receptor CXCR4 dimerization and inhibit HIV-1 entryWon-Tak Choi, Santhosh Kumar, Navid Madani, et al.Virology Journal|February 18, 2017
Evaluation of the contribution of the transmembrane region to the ectodomain conformation of the human immunodeficiency virus (HIV-1) envelope glycoproteinHanh T Nguyen, Navid Madani, Haitao Ding, et al.Plos Pathogens|May 12, 2020
Gp41-targeted antibodies restore infectivity of a fusion-deficient HIV-1 envelope glycoproteinVinita R Joshi, Ruchi M Newman, Melissa L Pack, et al.Biochemistry|February 18, 2004
Mode of action for linear peptide inhibitors of HIV-1 gp120 interactionsAlyssa C Biorn, Simon Cocklin, Navid Madani, et al.Plos Pathogens|April 4, 2009
Soluble CD4 and CD4-mimetic compounds inhibit HIV-1 infection by induction of a short-lived activated stateHillel Haim, Zhihai Si, Navid Madani, et al.Pageof 7